Levobunolol 0.5% and timolol 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy

Journal of Cataract and Refractive Surgery

Volumn 23, Issue 7, 1997, Pages 1075-1080

  Rakofsky, S ^a   Koch, D D ^a   Faulkner, J D ^a   Terry, S A ^a   Mandell, A I ^a   Gross, R L ^a   Kelley, E P ^a   Iacono, T L ^a   Lue, J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOBUNOLOL; TIMOLOL;

ADULT; AGED; ARTICLE; CAPSULOTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; NEODYMIUM LASER; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030881254     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(97)80083-1     Document Type: Article

References (14)